Suchergebnisse - "Yuan, Shuofeng"

PubPharm (35)

1

Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex

enthalten in: ACS infectious diseases | 2024

von Chen, J. | Zhou, Y. | Wei, X. | +10

2

PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness

enthalten in: Nature communications | 2024

von Liang, R. | Ye, Z. | Qin, Z. | +17

3

An enhanced broad-spectrum peptide inhibits Omicron variants in vivo

enthalten in: Cell reports. Medicine | 2024

von Bi, W. | Tang, K. | Chen, G. | +5

4

Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways

enthalten in: Journal of medical virology | 2024

von Yang, D. | Chan, J. | Yoon, C. | +20

5

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target

enthalten in: Nature communications | 2023

von Qin, B. | Li, Z. | Tang, K. | +6

6

A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo

enthalten in: Protein & cell | 2023

von Zuo, D. | Chen, Y. | Cai, J. | +16

7

Human early syncytiotrophoblasts are highly susceptible to SARS-CoV-2 infection

enthalten in: Cell reports. Medicine | 2022

von Ruan, D. | Ye, Z. | Yuan, S. | +16

8

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo

enthalten in: Cell reports. Medicine | 2022

von Chan, J. | Oh, Y. | Yuan, S. | +37

9

Metal-based strategies for the fight against COVID-19

enthalten in: Chemical communications (Cambridge, England) | 2022

von Li, H. | Yuan, S. | Wei, X. | +1

10

Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration

enthalten in: International journal of pharmaceutics | 2022

von Seow, H. | Liao, Q. | Lau, A. | +3